P1117: THREE-YEAR FOLLOW-UP OF OUTCOMES WITH KTE-X19 IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ZUMA-2

Journal article

Open access

Peer reviewed

M. L. Wang, J. Munoz, A. Goy, F. L. Locke, C. A. Jacobson, B. T. Hill, J. M. Timmerman, H. Holmes, I. W. Flinn, D. B. Miklos, …

HemaSphere, Vol.6(Suppl), pp.1007-1008

2022-06-23

Abstract

Posters

url

https://doi.org/10.1097/01.hs9.0000847336.10486.b2View

Published (Version of record) Open

1 Record Views

Title: P1117: THREE-YEAR FOLLOW-UP OF OUTCOMES WITH KTE-X19 IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ZUMA-2
Creators: M. L. Wang - The University of Texas MD Anderson Cancer Center
J. Munoz - Banner MD Anderson Cancer Center, Gilbert, AZ
A. Goy - John Theurer Cancer Center, Hackensack University, Hackensack, NJ
F. L. Locke - Moffitt Cancer Center
C. A. Jacobson - Dana–Farber Cancer Institute
B. T. Hill - Cleveland Clinic
J. M. Timmerman - David Geffen School of Medicine at UCLA
H. Holmes - Texas Oncology, Dallas, TX
I. W. Flinn - Sarah Cannon Research Institute
D. B. Miklos - Stanford University School of Medicine
J. M. Pagel - Swedish Cancer Institute
M. J. Kersten - University of Amsterdam
R. Houot - Inserm
A. Beitinjaneh - University of Miami
W. Peng - Kite
X. Fang - Kite
R. R. Shen - Kite
R. Siddiqi - Kite
I. Kloos - Kite
P. M. Reagan - University of Rochester Medical Center
Publication Details: HemaSphere, Vol.6(Suppl), pp.1007-1008
Publisher: Lippincott Williams & Wilkins
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031757904902976